Tumor-associated antigens (TAAs) are, by definition, weakly immunogenic. Strong antigen presentation by antigen-presenting cells (APCs) is required to sufficiently activate cytotoxic T cells (CTLs).

The scientists boosted the quality of the former step with algorithmic filters with a scope to find tumor antigen-bearing T-cells of high avidity, namely those capable of strong antigen binding.